Gyre Therapeutics president Ma Songjiang sells $22,336 in inventory By Investing.com
SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), lately offered a…
Soleno Therapeutics senior VP Patricia Hirano sells $138,709 in inventory By Investing.com
Patricia Hirano, Senior Vice President of Regulatory Affairs at Soleno Therapeutics Inc.…
RVNC ALERT: Kirby McInerney LLP Declares the Submitting of a Securities Class Motion on Behalf of Revance Therapeutics, Inc. Traders By Investing.com
New York, New York--(Newsfile Corp. - January 6, 2025) - The regulation…
Monopar Therapeutics units inventory and warrant providing costs By Investing.com
WILMETTE, Sick. - Monopar Therapeutics Inc . (NASDAQ:), a clinical-stage biopharmaceutical firm…
BioXcel Therapeutics inventory hits 52-week low at $0.35 By Investing.com
In a difficult market setting, BioXcel Therapeutics Inc (NASDAQ:). inventory has reached…
Viridian Therapeutics to Webcast Veligrotug Part 3 THRIVE-2 Topline Outcomes on December 16, 2024 By Investing.com
- THRIVE-2 world section 3 medical trial evaluated efficacy and security of…
Beam Therapeutics Pronounces New Knowledge from BEACON Section 1/2 Medical Trial of BEAM-101 in Sickle Cell Illness at American Society of Hematology (ASH) Annual Assembly By Investing.com
All Seven Sufferers Handled with BEAM-101 Achieved Hemoglobin F (HbF) Induction of…
Janux Therapeutics CEO sells $1 million in inventory By Investing.com
David Alan Campbell, President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), lately…
Rakovina Therapeutics Proclaims Personal Placement Providing By Investing.com
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…
Roche to amass US agency Poseida Therapeutics in $1.5 billion deal By Reuters
ZURICH (Reuters) -Switzerland's Roche will purchase U.S. biopharma agency Poseida Therapeutics in…
